Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs

摘要

The subject invention provides novel EGR-containing peptides and the use of these peptides in the treatment of various diseases and conditions. The novel peptides specifically bind to endothelial cells and various tumor cells and tissues.